Description
PCI provides full pharmaceutical manufacturing and drug development services for both investigational and commercial products including highly potent molecules requiring specialist handling.
Pharmaceutical Development: formulation development services available for a variety of dosage forms including tablets, capsules and powders; gels and creams; liquids, solutions, suspensions and emulsions; suppositories and pessaries; granules for reconstitution; and drugs in capsule/vial.
Clinical Trial Manufacturing: service available at each stage of the product lifecycle for a wide range of dosage forms, in full compliance with GMP regulatory standards for both highly potent and non-potent drug products.
Xcelodose® Microdosing Technology: drug delivery directly into capsules or vials using contained microdosing technology removes the need for initial formulation development and associated stability. Xcelohood™ and Xceloprotect™ technology for micro-dosing technologies enhances contained solutions for the development and manufacturing of highly potent drug products.
Commercial Manufacturing: flexible and globally compliant commercial scale manufacturing and packaging of multiple dosage forms including tablets, capsules, creams, gels, ointments and oral liquids for both highly potent and non-potent drug products.
Roller Compaction: granulation options for the development and manufacture of both highly potent and non-potent drug products.
Analytical Lab Services: available in-house laboratories providing a range of analytical services to support development, clinical and commercial supply.
QP Services: site audits, supply chain management, quality oversight, and release to market.
Specialized Manufacturing of Highly Potent Products:
Building on 35 years in potent processing, we offer two purpose-built manufacturing facilities in addition to a state-of-the-art packaging suite all utilizing the very latest in containment technology, enabling the safe development, clinical, and commercial scale manufacture of products with an Occupational Exposure Limit (OEL) as low as 0.01µg/m3.